Surrey Heartlands

Joint Formulary & PAD

Raloxifene hydrochloride - Breast cancer - chemoprevention

You are here : Home > Formulary Search > Raloxifene hydrochloride - Breast cancer - chemoprevention

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NICE
Un
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Raloxifene hydrochloride
Indication :
Breast cancer - chemoprevention
Group Name :
Keywords :
Brand Names Include :
Important Information :

Off-label use. Specialist initiation and prescribing for at least 1 month before any request is made for primary care prescribing.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Raloxifene hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Breast cancer - chemoprevention.

Committee Recommendations (1)

07 Aug 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed a formulary status for tamoxifen, anastrozole and raloxifene for chemoprevention in women at moderate or high risk of developing breast cancer for a duration of 5 years.

A BLUE (with specialist initiation) with 1 month prescribing by the specialist team following discussions with the patient about the risks and benefits of treatment.

Raloxifene (off-label for this indication) can be used:
- Postmenopausal in those with a uterus and have severe osteoporosis or do not wish to take anastrozole or tamoxifen if no past history or increased risk of thromboembolic disease

On occasion a patient may need time to consider treatment and may in those circumstances request that their GP prescribe. The GP will then need to consider if they have all the information from the specialist team in order to accept full clinical responsibility for prescribing for that patient.